The HCPLive conference coverage page features articles, videos, and expert-led live coverage from major medical meetings throughout the year.
Matthew Brams, MD: A Multidose ADHD Pill
CTx-1301's formulation enables 3 different doses within 1 pill for ADHD.
Matthew Brams, MD: Positive Results for CTx-1301 for Adults with ADHD
Researchers are prepared a phase 3 trial testing the treatment in adults with ADHD.
ADHD Coaching During COVID-19
The role of many in psychiatry has changed during the COVID-19 pandemic.
ADHD Polygenic Risk Scores May Benefit Pediatric Bipolar, Mood Disorder Understanding
Such scores could provide insight into the significant comorbidity rate of ADHD and other youth mood and emotional dysregulation issues.
ADHD Treatment Change Impacts Remote Patient Monitoring
Personalized, daily self-reporting for patients could influence future therapeutic strategies.
Adulthood Alcohol Problems Linked to Adolescent ADHD
Investigators have observed a development-related shift in risks from teenaged ADHD and alcohol use risks in the patients' 30s.
Better Interprofessional Communication Needed in ADHD Coaching
A pair of researchers present plans to improve collaboration with other professionals in ADHD.
Smoking Linked to Teenage ADHD Impulsivity, Inattention
The likelihood of smoking addiction is associated with traits also closely associated with worsened ADHD.
ADHD Coaching an Emerging Tool for Patients
An ADHD coach can work on more goal-based plans for individuals with ADHD.
Postnatal Smoke Exposure Likely Significant Risk Factor for ADHD in Children
A study finds that secondhand smoking may have a greater negative impact on children than prenatal smoke exposure.
Study Finds Parental Concerns of Autism Do Not Align with Reported Behaviors
There is a high association between parents' concerns of autism spectrum disorder in their children and identified symptoms of ADHD.
Deirdre McCarthy: The Long Pursuit of a Fragile X Syndrome Treatment
There is currently no approved treatment for fragile X syndrome.
Novel SMS Strategy May Help Increase Stimulant Adherence in Adults with ADHD
Current estimates indicate that non-adherence to stimulants is as high as 87%.
Sleep Regularity, Timing Could Influence ADHD Symptoms in Teens
New research expands on the understood link between sleep and ADHD-related behavior, and gives clinicians new therapeutic targets.
ADHD Impulsivity Linked to Greater COVID-19 Distress
Though the correlation is concerning for at-risk groups, experts believe it could inform individualized psychiatric care during crises.
ADHD Assessments Conducted Via Telehealth May Not Disadvantage Children
The APSARD study finds that most neuropsychological assessment scores did not differ significantly between both in-person and virtual visit modalities.
Andrew J. Cutler, MD: The Value of Delayed Release ADHD Treatments
Methylphenidate has shown promising boosting morning function in pediatric patients with ADHD.
Omega-3 Fatty Acids, Inositol Could Benefit Pediatric Bipolar Disorder
Both monotherapy and combination of the unique regimen was shown to improve manic and depressive status at 12 weeks.
Comorbidities Related to Pediatric ADHD May Be Characterized Using CBCL
The Child Behavior Checklist may provide invaluable information to clinicians regarding the type and severity of comorbid psychopathologies.
Andrew J. Cutler, MD: Delayed and Extended Release Methylphenidate Shows Promise
The treatment improves morning function for adolescent ADHD patients.
David W. Goodman, MD: Silver Linings in ADHD
Dr. David Goodman predicts some patients may improve their organizational skills during the pandemic.
David W. Goodman, MD: Adult ADHD Challenges During COVID-19
Adults with ADHD may face a number of challenges during the ongoing pandemic.
David W. Goodman, MD: APSARD 2021 Bringing Together International ADHD Research
The virtual conference will feature researchers from the US, Germany, Japan, and more.
Novel Educational Programs Can Benefit and Engage Sickle Cell Patients
Children with sickle cell disease have the opportunity to learn about STEM concepts in the context of their own condition.
The Absolute Benefit of Daratumumab for Relapsed Refractory Multiple Myeloma
A continued conversation on the intricate, patient-centric benefits of care with the subcutaneous agent.
Elliott Vichinsky, MD: Voxelotor and New HOPE Data for Sickle Cell
The UCSF hematologist discusses the growing portfolio for the sickle cell therapy after ASH 2020.
Sickle Cell Neurocognitive Screening Measures May Have Inherent Educational Bias
New ASH data demonstrates that RUDAS and MoCA scores are associated with highest level of education.
Luspatercept for Beta-Thalassemia May Reduce Transfusion Burden, Maintain QoL
Luspatercept added to best supportive care reduced transfusion burden while TranQol and SF-36 HRQoL scores were maintained through Week 48.
New Lintuzumab Combination Therapy for AML Safe, Potentially Effective
A Phase I study reports on the safety and potential efficacy of lintuzumab Ac225 plus CLAG-M for relapsed/refractory acute myeloid leukemia.
Largest Hemophilia B Gene Therapy Study to Date Hits Early Benefit, Safety Marks
The historic phase 3 HOPE-B trial shows all but 1 treated patient discontinued prophylaxis after a single dose of etranacogene deaparvovec.